SNN - Smith & Nephew plc

NYSE - NYSE Delayed Price. Currency in USD
37.93
-0.35 (-0.91%)
At close: 4:02PM EDT

37.93 0.00 (0.00%)
After hours: 4:02PM EDT

Stock chart is not supported by your current browser
Previous Close38.28
Open38.04
Bid37.90 x 100
Ask37.99 x 100
Day's Range37.92 - 38.24
52 Week Range26.97 - 40.43
Volume491,789
Avg. Volume558,071
Market Cap16.09B
Beta0.48
PE Ratio (TTM)19.31
EPS (TTM)1.96
Earnings DateN/A
Forward Dividend & Yield0.62 (1.62%)
Ex-Dividend Date2017-10-05
1y Target Est39.42
Trade prices are not sourced from all markets
  • Reuters7 hours ago

    Smith & Nephew to buy Rotation Medical for up to $210 million

    Medical technology group Smith & Nephew (SN.L), which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million (£159 million). The British company, best known for its replacement hips and knees, will pay an initial $125 million to acquire unlisted Minnesota-based Rotation Medical, plus up to $85 million over the next five years if certain financial targets are hit.

  • Reuters7 hours ago

    Smith & Nephew to buy Rotation Medical for up to $210 mln

    Medical technology group Smith & Nephew, which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million. The British company, best known for its replacement hips and knees, will pay an initial $125 million to acquire unlisted Minnesota-based Rotation Medical, plus up to $85 million over the next five years if certain financial targets are hit.

  • Capital Cube5 days ago

    ETFs with exposure to Smith & Nephew Plc : October 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Smith & Nephew Plc : SNN-US: Dividend Analysis : October 06th, 2017 (record date) : By the numbers : October 18, 2017
    Capital Cube5 days ago

    Smith & Nephew Plc : SNN-US: Dividend Analysis : October 06th, 2017 (record date) : By the numbers : October 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing Smith & Nephew Plc with the following peers – Zimmer Biomet Holdings, Inc., Johnson & Johnson, Edwards Lifesciences Corporation, Boston Scientific Corporation, Stryker Corporation, C. R. Bard, Inc., Exactech, Inc., Orthofix International NV and CONMED Corporation (ZBH-US, JNJ-US, EW-US, BSX-US, SYK-US, BCR-US, EXAC-US, OFIX-US and ... Read more (Read more...)

  • Financial Times12 days ago

    [$$] Elliott Management takes stakes in GEA and Smith & Nephew

    Elliott Management, Paul Singer's US hedge fund, has stepped up its activist campaigning in Europe, taking stakes in German food-processing machinery maker GEA and UK medical device maker Smith & Nephew. ...

  • Financial Times12 days ago

    [$$] Smith & Nephew: hippy hippy shake-up

    At 20 times forecast profits, shares in Smith & Nephew are rated like a growth stock. Yet adjusted earnings grew just 2 per cent a year between 2011 and 2016. Takeover speculation explains the divergence. ...

  • TheStreet.com12 days ago

    Smith & Nephew Surges to Record High on Reports of Elliott Stake

    Paul Singer's Elliott is said to have started building a stake in the maker of artificial hips and knees, sending shares higher.

  • Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark
    Investor's Business Daily13 days ago

    Smith & Nephew Shows Improved Relative Price Performance; Still Shy Of Benchmark

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Why MannKind, Nutanix, and Smith & Nephew Jumped Today
    Motley Fool13 days ago

    Why MannKind, Nutanix, and Smith & Nephew Jumped Today

    On a sunny day for the market, these stocks gained ground. Find out why.

  • Reuters13 days ago

    Elliott Management builds stake in Smith & Nephew - Bloomberg

    It is unclear how much stake the activist investor owns or what it plans to push for at the company, according to the Bloomberg report. "We do not comment on rumour or speculation and we do not comment on the identity of our investors other than those publicly disclosed," Smith & Nephew said in an emailed statement. Elliott declined to comment.

  • Elliott's Deal Magic Is Put to the Test
    Bloomberg13 days ago

    Elliott's Deal Magic Is Put to the Test

    The hedge fund has taken a stake in Smith & Nephew, which year after year has disappointed M&A speculators.

  • Singer's Elliott Builds a Stake in Smith & Nephew
    Bloomberg13 days ago

    Singer's Elliott Builds a Stake in Smith & Nephew

    Billionaire Paul Singer’s hedge fund Elliott Management Corp. has built a stake in Smith & Nephew Plc, the maker of artificial hips and knees, according to people familiar with the matter.

  • Stocks Showing Improved Relative Strength: Smith & Nephew
    Investor's Business Daily19 days ago

    Stocks Showing Improved Relative Strength: Smith & Nephew

    Smith & Nephew shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

  • Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks
    Zacks20 days ago

    Graham-Cassidy Fail Shines Spotlight on 3 Top Dividend Stocks

    Zeroing in on dividend stocks with a solid Zacks Rank is a great way to increase the chances of beating volatile market conditions while ensuring a steady stream of cash flow. Here are three top picks in the MedTech space.

  • Capital Cube20 days ago

    ETFs with exposure to Smith & Nephew Plc : October 3, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew
    Zackslast month

    The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

    The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

  • Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy
    Zackslast month

    Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy

    The fate of Obamacare will be decided on Sep. 30. No matter what the future holds, the day will provide investors a clear picture of where the MedTech industry is headed.

  • Capital Cubelast month

    ETFs with exposure to Smith & Nephew Plc : September 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • 5 British Stocks to Profit From a Weak Pound Sterling
    Zacks2 months ago

    5 British Stocks to Profit From a Weak Pound Sterling

    Companies exporting products and services stand to benefit from a weaker pound.

  • Capital Cube2 months ago

    ETFs with exposure to Smith & Nephew Plc : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Barrons.com2 months ago

    [$$] Medical Tech Bounces Back in Emerging Markets

    Wells Fargo Securities The median constant currency growth rate of the large-cap medical-tech companies in emerging markets (EM) was around 11% in the second quarter. The high median growth was due to nearly across the board sequential improvements in EM growth, which also drove up the average EM growth from about 9% in the first quarter to about 10% in the second quarter, The median EM growth of the large-cap med-tech companies continues to outpace the overall world-wide organic growth rate of 3.5% in the second quarter. The year-over-year (excluding exchange rates) growth of 3.5% for the large-cap med-tech sector in the quarter was the lowest rate we’ve seen since we began tracking this metric in the calendar first-quarter of 2015.

  • Capital Cube2 months ago

    ETFs with exposure to Smith & Nephew Plc : August 14, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Smith & Nephew Plc Here are 5 ETFs with the largest exposure to SNN-US. Comparing the performance and risk of Smith & Nephew Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Smith & Nephew Plc :SNN-US: Earnings Analysis: For the six months ended June 30, 2017 : July 31, 2017
    Capital Cube3 months ago

    Smith & Nephew Plc :SNN-US: Earnings Analysis: For the six months ended June 30, 2017 : July 31, 2017

    Categories: Yahoo FinanceGet free summary analysis Smith & Nephew Plc reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of Smith & Nephew Plc – Zimmer Biomet Holdings, Inc., Johnson & Johnson, Edwards Lifesciences Corporation, Boston Scientific Corporation, Stryker Corporation, C. R. Bard, Inc., Exactech, Inc. and ... Read more (Read more...)

  • Reuters4 months ago

    Robot wars: knee surgery marks new battleground for companies

    The world's top medical technology companies are turning to robots to help with complex knee surgery, promising quicker procedures and better results in operations that often leave patients dissatisfied. Demand for artificial replacement joints is growing fast, as baby boomers' knees and hips wear out, but for the past 15 years rival firms have failed to deliver a technological advance to gain them significant market share.

  • Elliott Said to Build Stake in Smith & Nephew
    Bloomberg Video13 days ago

    Elliott Said to Build Stake in Smith & Nephew

    Oct.11 -- Activist investor Paul Singer is honing in on Europe, building stakes in an engineering and healthcare company. An after hour statement revealed Singer's hedge fund Elliott Management added German engineering firm GEA to its portfolio and according to people familiar with the matter, it also took a stake in the British company Smith & Nephew. Bloomberg's Ruth David reports on "Bloomberg Markets: European Open."